Monocyte gene expression and coronary artery disease
- PMID: 23739627
- DOI: 10.1097/MCO.0b013e32836236f9
Monocyte gene expression and coronary artery disease
Abstract
Purpose of review: Despite current therapy, coronary artery disease (CAD) remains the major cause of morbidity and mortality worldwide. CAD is the consequence of a complex array of deranged metabolic processes including the immune system. In this context, monocytes and macrophages are indisputable players. Thus, monocyte gene expression analysis could be a powerful tool to provide new insights in the pathophysiology of CAD and improve identification of individuals at risk. We discuss current literature assessing monocyte gene expression and its association with CAD.
Recent findings: Monocyte surface markers CD14 ⁺⁺and CD16⁺ have been established as biomarkers for increased cardiovascular disease risk in a large number of studies. More in-depth gene expression analysis identified several interesting genes, such as ABCA1, CD36 and MSR1 with an increased expression in circulating monocytes from patients with CAD. The results for CD36 were replicated in one other study. For ABCA1 and MSR1 conflicting data are published.
Summary: Recent findings indicate that genetic differences exist in circulating monocytes of patients suffering from CAD, giving us more insights into the underlying mechanisms. However, larger studies are required to prove that monocytes' expression signature could serve as a marker for diagnostic purposes in the future.
Similar articles
-
CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart disease.Clin Exp Pharmacol Physiol. 2008 May;35(5-6):552-6. doi: 10.1111/j.1440-1681.2007.04836.x. Epub 2007 Dec 7. Clin Exp Pharmacol Physiol. 2008. PMID: 18067591
-
In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1.Scand J Immunol. 2009 Oct;70(4):368-76. doi: 10.1111/j.1365-3083.2009.02306.x. Scand J Immunol. 2009. PMID: 19751271
-
Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.J Mol Cell Cardiol. 2009 Feb;46(2):177-85. doi: 10.1016/j.yjmcc.2008.10.029. Epub 2008 Nov 14. J Mol Cell Cardiol. 2009. PMID: 19059264
-
New therapies for coronary artery disease: genetics provides a blueprint.Sci Transl Med. 2014 Jun 4;6(239):239ps4. doi: 10.1126/scitranslmed.3008535. Sci Transl Med. 2014. PMID: 24898745 Review.
-
Developing Peripheral Blood Gene Expression-Based Diagnostic Tests for Coronary Artery Disease: a Review.J Cardiovasc Transl Res. 2015 Aug;8(6):372-80. doi: 10.1007/s12265-015-9641-5. Epub 2015 Jun 25. J Cardiovasc Transl Res. 2015. PMID: 26109386 Review.
Cited by
-
Predictive Value of CFIm25 Expression in Peripheral Blood Monocytes for Coronary Atherosclerosis.Int J Med Sci. 2024 Jan 20;21(3):562-570. doi: 10.7150/ijms.91148. eCollection 2024. Int J Med Sci. 2024. PMID: 38322593 Free PMC article.
-
Association between rs1761667 polymorphism of CD36 gene and risk of coronary atherosclerosis in Egyptian population.Cardiovasc Diagn Ther. 2016 Apr;6(2):120-30. doi: 10.21037/cdt.2015.12.15. Cardiovasc Diagn Ther. 2016. PMID: 27054101 Free PMC article.
-
Comparative study of gene expression profiles rooted in acute myocardial infarction and ischemic/reperfusion rat models.Am J Cardiovasc Dis. 2020 Jun 15;10(2):84-100. eCollection 2020. Am J Cardiovasc Dis. 2020. PMID: 32685266 Free PMC article.
-
Cloning and expression of an anti-LDL(-) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosis.MAbs. 2013 Sep-Oct;5(5):763-75. doi: 10.4161/mabs.25859. Epub 2013 Jul 25. MAbs. 2013. PMID: 23924793 Free PMC article.
-
Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis.Nat Commun. 2017 Aug 30;8(1):393. doi: 10.1038/s41467-017-00517-4. Nat Commun. 2017. PMID: 28855511 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous